1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Fahrner, R.L.
Dieckmann, T.
Harwig, S.S.L.
Lehrer, R.I.
Eisenberg, D.
Feigon, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Chem.Biol.
CBOLE2
2050
1074-5521
3
543
550
10.1016/S1074-5521(96)90145-3
8807886
Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes.
1996
10.2210/pdb1pg1/pdb
pdb_00001pg1
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2164.679
PROTEGRIN-1
1
nat
polymer
no
yes
RGGRLCYCRRRFCVCVGR(NH2)
RGGRLCYCRRRFCVCVGRX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
pig
Sus
sample
9823
Sus scrofa
LEUKOCYTE
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_site
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1998-05-27
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
Y
BNL
1998-03-20
REL
LEAST RESTRAINT VIOLATION, LEAST GEOMETRY VIOLATION
100
20
NOESY
TOCSY
DQF-COSY
6.5
293
K
REFINEMENT DETAILS CAN BE FOUND IN THE JOURNAL CITATION ABOVE.
DISTANCE GEOMETRY SIMULATED ANNEALING
BRUNGER
refinement
X-PLOR
3.1
structure solution
AURELIA
structure solution
X-PLOR
3.1
500
Bruker
AMX500
ARG
1
n
1
ARG
1
A
GLY
2
n
2
GLY
2
A
GLY
3
n
3
GLY
3
A
ARG
4
n
4
ARG
4
A
LEU
5
n
5
LEU
5
A
CYS
6
n
6
CYS
6
A
TYR
7
n
7
TYR
7
A
CYS
8
n
8
CYS
8
A
ARG
9
n
9
ARG
9
A
ARG
10
n
10
ARG
10
A
ARG
11
n
11
ARG
11
A
PHE
12
n
12
PHE
12
A
CYS
13
n
13
CYS
13
A
VAL
14
n
14
VAL
14
A
CYS
15
n
15
CYS
15
A
VAL
16
n
16
VAL
16
A
GLY
17
n
17
GLY
17
A
ARG
18
n
18
ARG
18
A
NH2
19
n
19
NH2
19
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
LEU
5
A
O
LEU
5
A
N
VAL
16
A
N
VAL
16
1
A
A
O
H
ARG
ARG
9
11
1.55
1
A
A
HH12
O
ARG
ARG
1
4
1.59
1
A
A
HH11
O
ARG
GLY
1
2
1.60
2
A
A
HH22
O
ARG
GLY
1
17
1.44
2
A
A
HE
O
ARG
GLY
1
2
1.46
2
A
A
O
H
TYR
VAL
7
14
1.56
3
A
A
HE
O
ARG
GLY
1
2
1.42
3
A
A
HH22
O
ARG
GLY
1
17
1.46
3
A
A
HH21
O
ARG
GLY
1
3
1.47
3
A
A
O
H
TYR
VAL
7
14
1.48
3
A
A
H
O
LEU
VAL
5
16
1.56
3
A
A
O
H
ARG
ARG
9
11
1.60
4
A
A
HH21
O
ARG
GLY
1
3
1.39
4
A
A
HE
O
ARG
VAL
4
16
1.50
4
A
A
HE
O
ARG
ARG
1
4
1.52
4
A
A
O
H
ARG
ARG
9
11
1.53
4
A
A
O
H
LEU
VAL
5
16
1.59
5
A
A
HH21
O
ARG
GLY
1
2
1.46
5
A
A
O
H
ARG
ARG
9
11
1.49
5
A
A
HH12
O
ARG
GLY
1
17
1.52
5
A
A
O
H
LEU
VAL
5
16
1.59
6
A
A
O
H
TYR
VAL
7
14
1.52
6
A
A
O
HE
CYS
ARG
8
9
1.52
6
A
A
H
O
LEU
VAL
5
16
1.55
6
A
A
O
H
LEU
VAL
5
16
1.57
7
A
A
H3
O
ARG
GLY
1
17
1.45
7
A
A
O
HH21
GLY
ARG
2
18
1.47
8
A
A
HE
O
ARG
GLY
1
2
1.42
8
A
A
HH21
O
ARG
GLY
1
3
1.46
8
A
A
H
O
ARG
VAL
4
16
1.52
8
A
A
O
H
ARG
ARG
9
11
1.53
8
A
A
O
H
TYR
VAL
7
14
1.57
9
A
A
HE
O
ARG
VAL
4
16
1.49
9
A
A
HE
O
ARG
GLY
1
2
1.51
9
A
A
H
O
ARG
PHE
9
12
1.51
9
A
A
O
H
LEU
VAL
5
16
1.57
10
A
A
H1
O
ARG
GLY
1
17
1.42
10
A
A
O
H
ARG
ARG
9
11
1.56
10
A
A
O
H
LEU
VAL
5
16
1.59
11
A
A
HH12
O
ARG
ARG
1
4
1.45
11
A
A
HH11
O
ARG
GLY
1
2
1.49
11
A
A
O
H
ARG
ARG
9
11
1.52
11
A
A
O
H
LEU
VAL
5
16
1.58
12
A
A
H1
O
ARG
ARG
1
18
1.42
12
A
A
O
HE
GLY
ARG
17
18
1.47
12
A
A
O
H
LEU
VAL
5
16
1.58
12
A
A
H
O
ARG
PHE
9
12
1.58
13
A
A
O
H
TYR
VAL
7
14
1.45
13
A
A
O
H
ARG
ARG
9
11
1.50
13
A
A
H
O
LEU
VAL
5
16
1.55
14
A
A
H3
O
ARG
GLY
1
17
1.41
14
A
A
O
H
LEU
VAL
5
16
1.59
14
A
A
H
O
LEU
VAL
5
16
1.60
15
A
A
OH
HH21
TYR
ARG
7
9
1.47
15
A
A
O
H
TYR
VAL
7
14
1.53
15
A
A
O
H
ARG
ARG
9
11
1.54
15
A
A
H
O
ARG
PHE
9
12
1.57
16
A
A
HH12
O
ARG
GLY
1
3
1.54
16
A
A
HH22
O
ARG
GLY
1
17
1.58
17
A
A
HH21
O
ARG
GLY
1
2
1.45
17
A
A
O
H
TYR
VAL
7
14
1.58
17
A
A
O
HN1
GLY
NH2
3
19
1.58
18
A
A
H3
O
ARG
GLY
1
17
1.41
19
A
A
H1
OH
ARG
TYR
1
7
1.48
20
A
A
H1
O
ARG
ARG
1
4
1.43
20
A
A
O
H
ARG
ARG
9
11
1.50
20
A
A
O
H
LEU
VAL
5
16
1.53
1
A
ARG
10
60.22
-58.90
1
A
ARG
11
-146.39
14.74
2
A
ARG
10
62.05
-65.23
2
A
ARG
11
-148.11
20.81
3
A
ARG
10
61.98
-62.01
3
A
ARG
11
-147.60
18.08
4
A
ARG
4
68.98
139.74
4
A
ARG
10
59.42
-56.34
4
A
ARG
11
-145.66
11.95
5
A
ARG
10
59.34
-54.23
5
A
ARG
11
-146.53
11.46
8
A
ARG
10
59.51
-56.51
8
A
ARG
11
-146.37
14.28
9
A
ARG
4
68.65
137.44
9
A
PHE
12
178.51
151.00
10
A
ARG
10
60.10
-59.18
10
A
ARG
11
-144.92
15.12
11
A
ARG
4
66.49
150.23
11
A
ARG
10
59.49
-56.46
11
A
ARG
11
-144.41
11.26
12
A
LEU
5
171.01
157.02
12
A
PHE
12
163.77
174.18
13
A
ARG
10
55.79
-56.21
14
A
ARG
11
-145.62
37.04
15
A
ARG
10
59.64
-56.88
15
A
ARG
11
-146.85
14.51
16
A
ARG
10
69.71
-62.90
16
A
ARG
11
-170.30
22.08
16
A
PHE
12
173.50
175.55
17
A
LEU
5
179.88
168.19
17
A
ARG
11
81.76
22.17
18
A
PHE
12
157.67
-179.53
19
A
LEU
5
151.14
-176.48
19
A
ARG
11
91.53
13.17
20
A
ARG
10
58.62
-54.85
20
A
ARG
11
-143.39
10.40
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
PROTEGRIN 1 (PG1) FROM PORCINE LEUKOCYTES, NMR, 20 STRUCTURES
1
Y
N
disulf
2.022
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
15
A
SG
CYS
15
1_555
disulf
2.025
A
CYS
8
A
SG
CYS
8
1_555
A
CYS
13
A
SG
CYS
13
1_555
covale
1.303
both
A
ARG
18
A
C
ARG
18
1_555
A
NH2
19
A
N
NH2
19
1_555
ANTIMICROBIAL PEPTIDE
ANTIMICROBIAL PEPTIDE
PG1_PIG
UNP
1
1
P32194
METQRASLCLGRWSLWLLLLALVVPSASAQALSYREAVLRAVDRLNEQSSEANLYRLLELDQPPKADEDPGTPKPVSFTV
KETVCPRPTRQPPELCDFKENGRVKQCVGTVTLDQIKDPLDITCNEVQGVRGGRLCYCRRRFCVCVGRG
131
148
1PG1
1
18
P32194
A
1
1
18
2
anti-parallel
A
ARG
4
A
ARG
4
A
ARG
9
A
ARG
9
A
PHE
12
A
PHE
12
A
GLY
17
A
GLY
17
BINDING SITE FOR RESIDUE NH2 A 19
A
NH2
19
Software
2
A
GLY
17
A
GLY
17
2
1_555
A
ARG
18
A
ARG
18
2
1_555
1
P 1